R. Michael Carruthers serves as Executive at Nivalis Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, R. Michael Carruthers has executed 17 insider transactions totaling $5.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2025 involved selling 1,428 shares valued at $19.1K.
R. Michael Carruthers currently holds 86,162 shares of Nivalis Therapeutics, Inc. (NVLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, R. Michael Carruthers has been a net seller of NVLS stock. They have purchased $50.2K and sold $5.1M worth of shares.
R. Michael Carruthers's most recent insider trade was on Aug 12, 2025, when they sold 1,428 shares at $13.39 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 20, 2024 | EWTX | $1.4M | Sale | 50,000 | $28.55 | Discretionary |
| Sep 20, 2024 | EWTX | $96.5K | Option Exercise | 50,000 | $1.93 | Discretionary |
| Sep 20, 2024 | EWTX | $713.6K | Sale | 24,960 | $28.59 | Discretionary |
| Sep 20, 2024 | EWTX | $116.2K | Sale | 4,064 | $28.59 | Discretionary |
| Sep 20, 2024 | EWTX | $1.3M | Sale | 46,068 | $28.59 | Discretionary |
| Sep 20, 2024 | EWTX | $88.9K | Option Exercise | 46,068 | $1.93 | Discretionary |
| May 2, 2024 | EWTX | $40.8K | Sale | 2,157 | $18.91 | Discretionary |
| May 1, 2024 | EWTX | $0 | Option Exercise | 5,208 | $N/A | Discretionary |
| Jan 23, 2024 | EWTX | $1.4M | Sale | 90,000 | $15.78 | Planned |
| Jan 23, 2024 | EWTX | $173.7K | Option Exercise | 90,000 | $1.93 | Planned |
| Jun 22, 2023 | EWTX | $7.1K | Option Exercise | 10,000 | $0.71 | Discretionary |
| May 2, 2023 | EWTX | $11.9K | Sale | 1,336 | $8.90 | Discretionary |
| May 1, 2023 | EWTX | $0 | Option Exercise | 5,208 | $N/A | Discretionary |
| May 23, 2022 | EWTX | $6.4K | Option Exercise | 9,000 | $0.71 | Discretionary |
| Dec 2, 2016 | NVLS | $50.2K | Purchase | 24,000 | $2.09 | Discretionary |